Parallels Between Major Depressive Disorder and Alzheimer’s Disease: Role of Oxidative Stress and Genetic Vulnerability
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
The thesis of this review is that oxidative stress is the central factor in major depressive disorder (MDD) and Alzheimer’s disease (AD). The major elements involved are inflammatory cytokines, the hypothalamic–pituitary axis, the hypothalamic–pituitary gonadal, and arginine vasopressin systems, which induce glucocorticoid and “oxidopamatergic” cascades when triggered by psychosocial stress, severe life-threatening events, and mental-affective and somatic diseases. In individuals with a genomic vulnerability to depression, these cascades may result in chronic depression–anxiety–stress spectra, resulting in MDD and other known depressive syndromes. In contrast, in subjects with genomic vulnerability to AD, oxidative stress-induced brain damage triggers specific antioxidant defenses, i.e., increased levels of amyloid-β (Aβ) and aggregation of hyper-phosphorylated tau, resulting in paired helical filaments and impaired functions related to the ApoEε4 isoform, leading to complex pathological cascades culminating in AD. Surprisingly, all the AD-associated molecular pathways mentioned in this review have been shown to be similar or analogous to those found in depression, including structural damage, i.e., hippocampal and frontal cortex atrophy. Other interacting molecular signals, i.e., GSK-3β, convergent survival factors (brain-derived neurotrophic factor and heat shock proteins), and transition redox metals are also mentioned to emphasize the vast array of intermediates that could interact via comparable mechanisms in both MDD and AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Free Radicals in Biology and Medicine
Halliwell, B., & Gutteridge, J. M. C. (2015) · doi:10.1093/acprof:oso/9780198717478.001.0001 · Cited by 8,990
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856
Oxidative Stress, Glutamate, and Neurodegenerative Disorders
Coyle, J. T., & Puttfarcken, P. (1993) · Science · doi:10.1126/science.7901908 · Cited by 3,762 · cited 3×
“…this question to be exceptionally significant and explanatory, since oxidative stress and hippocampal-cortical atrophy are currently considered (Coyle and Puttfarcken 1993; de Leon et al. 1997; Jellinger 2007; de Leon et al. 1989; 936 Cell Mol Neurobiol (2014) 34:925–949 Lupien et al. 1998) to…”
InfluentialBrain corticosteroid receptor balance in health and disease
de Kloet, E. R., Vreugdenhil, E., Oitzl, M. S., & Joëls, M. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.3.0331 · Cited by 2,614 · cited 2×
“…there are also strong molecular and cellular influences on serotonergic transmission, neuronal excitability, and behavioral responses in addition to hypothalamic–pituitary–adrenal regulation, effects that are relevant and consistent with our suggestions (De Kloet et al. 1998; Bitran et al. 1998).”
Brain corticosteroid receptor balance in health and disease
de Kloet, E. R. (1998) · Endocrine Reviews · doi:10.1210/er.19.3.269 · Cited by 2,614
The neuroendocrinology of stress and aging: The glucocorticoid cascade hypothesis
SAPOLSKY, R. M., KREY, L. C., & McEWEN, B. S. (1986) · Endocrine Reviews · doi:10.1210/edrv-7-3-284 · Cited by 2,298
Neurocircuitry of stress: central control of the hypothalamo–pituitary–adrenocortical axis
Herman, J. P., & Cullinan, W. E. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10069-2 · Cited by 2,270 · cited 1×
“…regions, acting as negative feedback and tonic inhibitory influences (De Kloet and Reul 1987; De Kloet et al. 1998) at the hypothalamic and pituitary level and at the pyramidal (CA1–4) and granular (dentate-gyrus) neurons of the hippocampus (Herman et al. 1989; Herman and Cullinan 1997).”
STRESS AND HIPPOCAMPAL PLASTICITY
McEwen, B. S. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.105 · Cited by 2,087 · cited 1×
“Stress inhibits neurogenesis through cortisol action in the hippocampus, leading to hippocampal atrophy (McEwen 1999; Magarinos et al. 1997).”
Memantine in Moderate-to-Severe Alzheimer's Disease
Reisberg, B., Doody, R., Stöffler, A., Schmitt, F., Ferris, S., & Möbius, H. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa013128 · Cited by 2,043
Hippocampal atrophy in recurrent major depression
Sheline, Y. I., Wang, P. W., Gado, M. H., Csernansky, J. G., & Vannier, M. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.3908 · Cited by 1,932 · cited 2×
“In previous sections, it was shown that hippocampal atrophy is associated with chronic stress and MDDs in more than 55%of affected individuals (Sheline et al. 1996) and, thatMK801, an NMDA antagonist, attenuates dendritic hippocampal loss and other damage incited by stimulation of NMDARs (Nitsch and Frotscher 1992).”
Oxidative Damage Is the Earliest Event in Alzheimer Disease
Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., et al. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.8.759 · Cited by 1,885 · cited 6×
“…is not consistent with many clinical and pathological phenotypes currently found (Perry et al. 2000b; Smith et al. 2002), the functions of iron-monomeric Aβ-ApoEε4 binding (Rodrigues et al. 2010) and of early defenses against oxidative stress from the beginning of AD (Nunomura et al. 2001).”
InfluentialSelf-citationJACOBSON, L., & SAPOLSKY, R. (1991) · Endocrine Reviews · doi:10.1210/edrv-12-2-118 · Cited by 1,739
Cortisol levels during human aging predict hippocampal atrophy and memory deficits
Lupien, S. J., de Leon, M., de Santi, S., Convit, A., Tarshish, C., Nair, N. P. V., Thakur, M., McEwen, B. S., Hauger, R. L., & Meaney, M. J. (1998) · Nature Neuroscience · doi:10.1038/271 · Cited by 1,653 · cited 1×
“…exceptionally significant and explanatory, since oxidative stress and hippocampal-cortical atrophy are currently considered (Coyle and Puttfarcken 1993; de Leon et al. 1997; Jellinger 2007; de Leon et al. 1989; 936 Cell Mol Neurobiol (2014) 34:925–949 Lupien et al. 1998) to be associated with AD.”
Ownby, R. L., Crocco, E., Acevedo, A., John, V., & Loewenstein, D. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.5.530 · Cited by 1,493 · cited 1×
“…been performed, including systematic reviews and complete meta-analyses of the relationship between depression and AD; for example, the report of Ownby et al. (2006) concluded— after a pooled and meta-regression analyses of 20 selected studies aggregating 102,172 persons in 8 countries and…”
Gould, E., Tanapat, P., McEwen, B. S., Flügge, G., & Fuchs, E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3168 · Cited by 1,395 · cited 4×
“For more than a decade, antidepressants have been thought to have an attenuated action on stress-induced alterations in brain metabolism, hippocampal volume, and cell proliferation (Czéh et al. 2001; Gould et al. 1998; Sapolsky 2001), particularly in acute syndromes (Holsboer et al. 1995).”
InfluentialThe role of corticotropin-releasing factor in depression and anxiety disorders
Arborelius, L., Owens, M., Plotsky, P., & Nemeroff, C. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1600001 · Cited by 1,378 · cited 1×
“…establish that the stress (in this context psychological stress) response by the brain is mediated through the hypothalamic–pituitary– adrenal axis, most likely, though not firmly established, by stimuli brought from the amygdalae nuclei and other neural systems (Arborelius et al. 1999).”
New insights into BDNF function in depression and anxiety
Martinowich, K., Manji, H., & Lu, B. (2007) · Nature Neuroscience · doi:10.1038/nn1971 · Cited by 1,221 · cited 24×
“Turning to mood disorders, the work of Martinowich et al. (2007) on BDNF function in depression and anxiety underscores that antidepressant drugs may upregulate this survival protein.”
InfluentialHippocampal damage associated with prolonged glucocorticoid exposure in primates
Sapolsky, R., Uno, H., Rebert, C., & Finch, C. (1990) · The Journal of Neuroscience · doi:10.1523/jneurosci.10-09-02897.1990 · Cited by 1,103
The acute effects of corticosteroids on cognition: integration of animal and human model studies
LUPIEN, S., & MCEWEN, B. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00004-0 · Cited by 1,024 · cited 2×
“Furthermore, after these and many other relevant studies over the last two decades (Lupien et al. 1994, 1995; Lupien and McEwen 1997; Scolville and Milner 1957; Porter and Landsfield 1998; Sapolsky 2001; Czéh et al. 2001), hippocampal atrophy has been quantitatively associated and positively…”
The stress system in the human brain in depression and neurodegeneration
Swaab, D. F., Bao, A.-M., & Lucassen, P. J. (2005) · Ageing Research Reviews · doi:10.1016/j.arr.2005.03.003 · Cited by 984 · cited 3×
“…of Swaab et al. (2005) and Swaab and Bao (2011) opened a large track to investigate almost all of the aforementioned interactions and, in spite of some paradoxical data (Swaab et al. 2005), the researchers' past and recent findings established a clear consensus that is consistent with our proposal.”
InfluentialIncreased hippocampal neurogenesis in Alzheimer's disease
Jin, K., Peel, A. L., Mao, X. O., Xie, L., Cottrell, B. A., Henshall, D. C., & Greenberg, D. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2634794100 · Cited by 971 · cited 2×
“On the other hand, BDNF and other NGFs induce neurogenesis in the sub-granular-neuroproliferative zone of the dentategyrus and CA1 region of Amon’s horn in the adult brain (Kunkin et al. 2004).”
Maes, M., Yirmyia, R., Noraberg, J., Brene, S., Hibbeln, J., Perini, G., Kubera, M., Bob, P., Lerer, B., & Maj, M. (2009) · Metabolic Brain Disease · doi:10.1007/s11011-008-9118-1 · Cited by 894
Activation of p75NTR by proBDNF facilitates hippocampal long-term depression
Woo, N. H., Teng, H. K., Siao, C.-J., Chiaruttini, C., Pang, P. T., Milner, T. A., Hempstead, B. L., & Lu, B. (2005) · Nature Neuroscience · doi:10.1038/nn1510 · Cited by 815 · cited 2×
“…heat shock proteins (HSPs) and/or protecting chaperones (Allagy et al. 2009); and antidepressant drugs may up-regulate BDNF (Martinowich et al. 2007; Terracciano et al. 2011), invoking the " neurotropic hypothesis of depression " (Martinowich et al. 2007; Terracciano et al. 2011; Woo et al. 2005).”
Noble, W., Planel, E., Zehr, C., Olm, V., Meyerson, J., Suleman, F., Gaynor, K., Wang, L., LaFrancois, J., Feinstein, B., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500466102 · Cited by 709 · cited 2×
“Moreover, the action of lithium on AD may be assessed by its inhibitor action on GSK-3β-causing reduced tauopathy and neurodegenerative effect (Noble et al. 2005), and its indirect action should be investigated in manic depression associated with AD to determine whether patients with manic depression that receive lith…”
The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death
Sapolsky, R. M. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00971-9 · Cited by 699 · cited 1×
“…hormones, particularly the glucocorticoids, mediate this " cross-talk " between depression and hippocampal lesions (Bremner 1999) through disruption of cellular metabolism (Sapolsky et al. 1990; Sapolski 2000) and altering synaptic structures in specific areas such as CA1 (Magarinos et al. 1997).”
Lithium-induced increase in human brain grey matter
Moore, G. J., Bebchuk, J. M., Wilds, I. B., Chen, G., & Menji, H. K. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02793-8 · Cited by 649 · cited 2×
“Furthermore , lithium was the first mineral agent that protected brain cells from premature death, and that may even cause brain cells to regenerate after a loss from disease (Moore et al. 2000).”
Nuclear factor-κB is a critical mediator of stress-impaired neurogenesis and depressive behavior
Koo, J. W., Russo, S. J., Ferguson, D., Nestler, E. J., & Duman, R. S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910658107 · Cited by 607
Basal cortisol levels and cognitive deficits in human aging
Lupien, S., Lecours, A., Lussier, I., Schwartz, G., Nair, N., & Meaney, M. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-05-02893.1994 · Cited by 566
Depression as a Risk Factor for Alzheimer Disease: The MIRAGE Study
Green, R. C., Cupples, L. A., Kurz, A., Auerbach, S., Go, R., Sadovnick, D., Duara, R., Kukull, W. A., Chui, H., Edeki, T., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.5.753 · Cited by 551 · cited 3×
“This result suggests models for AD and MDD, which are consistent with clinical and statistical reports (Green et al. 2003).”
Chronic stress alters synaptic terminal structure in hippocampus
Magariños, A. M., Verdugo, J. M. G., & McEwen, B. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.14002 · Cited by 543 · cited 6×
“1990; Sapolski 2000) and altering synaptic structures in specific areas such as CA1 (Magarinos et al. 1997).”
InfluentialDepressive symptoms, cognitive decline, and risk of AD in older persons
Wilson, R. S., Barnes, L. L., Mendes de Leon, C. F., Aggarwal, N. T., Schneider, J. S., Bach, J., Pilat, J., Beckett, L. A., Arnold, S. E., Evans, D. A., et al. (2002) · Neurology · doi:10.1212/wnl.59.3.364 · Cited by 528
Oxidative stress and gene expression in sepsis
Macdonald, J., Galley, H. F., & Webster, N. R. (2003) · British Journal of Anaesthesia · doi:10.1093/bja/aeg034 · Cited by 497
A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives
Benes, F. M., Kwok, E. W., Vincent, S. L., & Todtenkopf, M. S. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00138-3 · Cited by 470
Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease
De Leon, M. J., George, A. E., Golomb, J., Tarshish, C., Convit, A., Kluger, A., De Santi, S., Mc Rae, T., Ferris, S. H., Reisberg, B., et al. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(96)00213-8 · Cited by 429 · cited 2×
“Furthermore, increased cortisol levels in AD are correlated with hippocampal atrophy (de Leon et al. 1997), and the cortisol response to the opioid antagonist naltrexone was absent in AD in individuals of comparable age to healthy controls who show elevated cortisol levels in this situation.”
Glutamate and Depression: Clinical and Preclinical Studies
PAUL, I. A., & SKOLNICK, P. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.016 · Cited by 408 · cited 2×
“Finally, the interesting study of Paul and Skolnick (Paul and Skolnick 2003) on glutamate, NMDA receptor, and AMPA receptor effects on depression and suicide symptoms to promote more effective antidepressant treatments in anxiety–depressive patients indicates that the use of integrated excitatory amino acids antagonis…”
Akiskal, H. S., & McKinney, W. T. (1973) · Science · doi:10.1126/science.182.4107.20 · Cited by 389 · cited 2×
“Nevertheless, in our opinion, one of the most useful approaches to depression, which includes neurobiological, cellular, and molecular studies, is reported by Akiskal and McKinney (1973).”
Maes, M., Lin, A.-H., Delmeire, L., Van Gastel, A., Kenis, G., De Jongh, R., & Bosmans, E. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00131-0 · Cited by 387 · cited 1×
“When PTSD is a co-morbidity with MDD, IL-6 is higher in serum and is involved in the catecholaminergic modulation of anxiety reactions (Maes et al. 1999).”
Stress and hippocampal plasticity: implications for the pathophysiology of affective disorders
McEwen, B. S., & Magarinos, A. M. (2001) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.266 · Cited by 349 · cited 4×
“The pioneering studies of McEwen and Magarinos (2001) have shown that the hippocampus, which is involved in declarative, spatial, and contextual memory, is very sensitive to stress and gonadal hormones.”
InfluentialWarner-Schmidt, J. L., Vanover, K. E., Chen, E. Y., Marshall, J. J., & Greengard, P. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104836108 · Cited by 291
EARLY MARKER FOR ALZHEIMER'S DISEASE: THE ATROPHIC HIPPOCAMPUS
De Leon, M., George, A., Stylopoulos, L., Smith, G., & Miller, D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90911-2 · Cited by 284 · cited 1×
“…exceptionally significant and explanatory, since oxidative stress and hippocampal-cortical atrophy are currently considered (Coyle and Puttfarcken 1993; de Leon et al. 1997; Jellinger 2007; de Leon et al. 1989; 936 Cell Mol Neurobiol (2014) 34:925–949 Lupien et al. 1998) to be associated with AD.”
A common substrate for prefrontal and hippocampal inhibition of the neuroendocrine stress response
Radley, J. J., & Sawchenko, P. E. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.6040-10.2011 · Cited by 251
Caccamo, A., Maldonado, M. A., Bokov, A. F., Majumder, S., & Oddo, S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012851108 · Cited by 249
Geerlings, M. I., den Heijer, T., Koudstaal, P. J., Hofman, A., & Breteler, M. M. B. (2008) · Neurology · doi:10.1212/01.wnl.0000308937.30473.d1 · Cited by 248
Life Events and Endogenous Depression: A Puzzle Reexamined
Brown, G. W. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950070017006 · Cited by 230 · cited 2×
“…codified and understood because these classifications are observational and lack underlying pathogenic cellular and molecular neurobiological and pharmacologicetiologic mechanisms and phenotypes (Gruenberg et al. 2005; Starkstein et al. 2005; Akiskal and Lewis 2005; Brown et al. 1994; Parker 2000).”
Hippocampal Morphology and Distinguishing Late-Onset From Early-Onset Elderly Depression
Ballmaier, M., Narr, K. L., Toga, A. W., Elderkin-Thompson, V., Thompson, P. M., Hamilton, L., Haroon, E., Pham, D., Heinz, A., & Kumar, A. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07030506 · Cited by 226 · cited 4×
“This damage is prevented by the use of antidepressant treatments (Czéh et al. 2001; Ballmaier et al. 2008), particularly in aged subjects with long-term depression (Landfield and Linch 1978; Issa et al. 1990).”
InfluentialBaumann, B., Danos, P., Krell, D., Diekmann, S., Leschinger, A., Stauch, R., Wurthmann, C., Bernstein, H.-G., & Bogerts, B. (1999) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.11.1.71 · Cited by 198 · cited 2×
“…substantial gray matter reduction and decreased neuron density in prefrontal cortex, the volume decrease of left nucleus accumbens-right putamen (Baumann et al. 1999; Rajkowska 2000; Vincent et al. 1997), the reduction in specific layers enclosing the interneurons in the anterior cingulated…”
NGF and BDNF signaling control amyloidogenic route and Aβ production in hippocampal neurons
Matrone, C., Ciotti, M. T., Mercanti, D., Marolda, R., & Calissano, P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806133105 · Cited by 169 · cited 1×
“…to cyclic AMP response element binding protein and stimulating DNA synthesis (Caccamo et al. 2010) through control of the amyloidogenic pathway and Aβ production in hippocampal neurons (Matrone et al. 2008) and through stimulating neural stem cells to improve cognition (Blurton-Jones et al. 2009).”
Cited by
Czarny, P., Wigner, P., Galecki, P., & Sliwinski, T. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.06.036 · Cited by 310
“…mechanisms of pathogenesis on cellular and molecular levels, and are based on observations only, depressive syndromes still cannot be clearly codified and understood [Brown et al. 1994, Parker 2000, Gruenberg et al. 2005, Akiskal and Lewis 2005, Starkstein et al. 2005, Rodrigues et al. 2014].”
BackgroundThe Roles of Flavonols/Flavonoids in Neurodegeneration and Neuroinflammation
Calis, Z., Mogulkoc, R., & Baltaci, A. K. (2020) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557519666190617150051 · Cited by 196
Caraci, F., Spampinato, S. F., Morgese, M. G., Tascedda, F., Salluzzo, M. G., Giambirtone, M. C., Caruso, G., Munafò, A., Torrisi, S. A., Leggio, G. M., et al. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.02.007 · Cited by 172
Herbert, J., & Lucassen, P. J. (2016) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2015.12.001 · Cited by 150
Viayna, E., Coquelle, N., Cieslikiewicz-Bouet, M., Cisternas, P., Oliva, C. A., Sánchez-López, E., Ettcheto, M., Bartolini, M., De Simone, A., Ricchini, M., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01775 · Cited by 106
Metadata
- Authors
- Rodrigues, R., Petersen, R. B., & Perry, G.
- Venue
- Cellular and Molecular Neurobiology
- Published
- 2014-06-14
- Volume
- 34
- Issue
- 7
- Pages
- 925-949
- ISSN
- 0272-4340 (ISSN-L)
- 1573-6830
- OpenAlex
- W2065128997
- Cited by
- 99
- References
- 47
- FWCI
- 3.70
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.